Oct 28, 2025, 01:01 AM by User Not Found

Bio-IT World | Kailera Therapeutics advances injectable dual GLP-1/GIP receptor agonist; Tubulis develops antibody-drug conjugate for ovarian cancer and lung adenocarcinomas; Trogenix advances their pipeline of potentially curative cancer therapies across multiple aggressive solid tumors into the clinic; and more.

Oct 28, 2025, 01:00 AM by User Not Found

Bio-IT World | Kailera Therapeutics advances injectable dual GLP-1/GIP receptor agonist; Tubulis develops antibody-drug conjugate for ovarian cancer and lung adenocarcinomas; Trogenix advances their pipeline of potentially curative cancer therapies across multiple aggressive solid tumors into the clinic; and more.

Oct 24, 2025, 09:10 AM by

Leading Global Cancer Center to Integrate Triomics AI Platform to Improve Clinical Trial Screening

Oct 24, 2025, 09:10 AM by

Elixion Biotech has emerged from stealth with a breakthrough that could reshape early-stage drug discovery. In just eleven months, and without external funding, the Zurich-based therapeutics company has validated its quantum physics-informed R&D process, confirming its ability to accurately predict and identify novel drug targets. The milestone positions Elixion to advance its precision-oncology pipeline and opens the door to seed-stage investment.

Oct 24, 2025, 09:10 AM by

Oct 23, 2025, 08:15 AM by

Oct 23, 2025, 08:15 AM by

Recognized for Global Precision Health Informatics Industry Excellence in Best Practices

Oct 23, 2025, 08:15 AM by

Oct 23, 2025, 08:15 AM by

Ansa Biotechnologies announced the full commercial launch of its 50kb Clonal DNA product – the longest sequence-perfect synthetic DNA commercially available.

Oct 23, 2025, 08:15 AM by

Oct 23, 2025, 08:15 AM by

Oximio, a global leader in supply chain solutions for the clinical research industry, is delighted to welcome Bay Area Research Logistics (BARL), Canada to the Oximio family with the agreement signed on 17th October 2025, a strategic move that strengthens Oximio’s global footprint and enhances its capabilities across the globe.

Oct 23, 2025, 01:01 AM by User Not Found

Bio-IT World | Researchers have developed a generative transformer model capable of forecasting an individual’s risk of developing over 1,200 diseases a decade in advance. The model, called Delphi-2M, was validated using data on about 2 million individuals from Denmark’s National Patient Registry without retraining.

Oct 22, 2025, 07:10 AM by

Sionna Therapeutics has initiated its Phase 2a PreciSION CF trial evaluating SION-719, the first NBD1 stabilizer, in combination with Trikafta in people with cystic fibrosis. The study marks the first time an NBD1 stabilizer has been tested alongside the current standard of care, representing a key step toward validating NBD1 as a novel, synergistic mechanism to further improve CFTR function.

Oct 22, 2025, 07:10 AM by

Oct 22, 2025, 01:01 AM by User Not Found

Bio-IT World | A breakthrough in rheumatoid arthritis (RA) research may redefine how and when the autoimmune disease is diagnosed and treated. A team of researchers from the University of Colorado Anschutz., the Allen Institute for Immunology, and UC San Diego have mapped immune changes that occur years before the first swollen joint appears.

Oct 21, 2025, 08:45 AM by

Oct 21, 2025, 08:45 AM by

Open-science research initiative, COVID Moonshot and the AI-driven Structure-enabled Antiviral Platform (ASAP) consortium, delivered a promising pre-clinical candidate 2,000 new compounds generated for the programme are now available from Enamine’s catalogue

Oct 21, 2025, 08:45 AM by

Biopharma PEG Scientific Inc. has expanded its portfolio of monodispersed azide-PEG derivatives to support bioconjugation, ADC linker development, and nanoparticle surface modification. The company now offers GMP-standard manufacturing from milligram to 100-kilogram scale, ensuring consistency and scalability for research and preclinical use.

Oct 21, 2025, 08:45 AM by

18 Encode AI fellows will be embedded into cutting-edge scientific labs across the UK

Oct 21, 2025, 01:00 AM by User Not Found

Bio-IT World | Last month, the Longitude Prize on ALS announced the judgement panel for the prize. The panel consists of leaders and experts from neuroscience, technology, and pharmaceutical fields from around the world.